Phototherapeutic Keratectomy (PTK) With Mitomycin in Adenoviral Opacities
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00492245
Verified July 2008 by Federal University of São Paulo. Recruitment status was: Active, not recruiting
The present study was designed to evaluate the treatment of adenoviral corneal opacities with PTK and mitomycin C.
Condition or disease
Procedure: PTK with mitomycin in Adenoviral Opacities
Epidemic keratoconjunctivitis is a very common disease, some patients developed a complication after the infection wich is corneal infiltration. Topical treatment sometimes helps to avoid loss of visual acuity. Therefore recurrence of the opacities after topical drops is observed. When corneal fibrosis occur is difficult to achieve visual rehabilitation with topical approach. This study evaluate pre and postoperative data of patients with subepithelial fibrosis caused by adenoviral infiltrates submitted to phototherapeutic keratectomy (PTK) using mitomycin C.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 80 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
visual acuity worse than 20/40, caused by central subepithelial fibrosis
pregnancy, age less than 18 years-old or more than 80 years-old.
diabetes, autoimmune diseases, corneal thickness less tha 400 micron.